Pheochromocytoma risk factors
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma risk factors On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma risk factors |
|
Risk calculators and risk factors for Pheochromocytoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview
Pheochromocytoma is more common in people between 40 and 60 years old, men, people with family history of multiple endocrine neoplasias, von Hippel-Lindau disease, neurofibromatosis 1, hereditary paraganglioma syndromes.
Risk Factors
The most potent risk factors of pheochromocytoma are:
Age
Occurs in third to fifth decades of life; the average age at diagnosis is 24.9 years in hereditary cases and 43.9 years in sporadic cases.[1]
Hereditary tumors present at a younger age than sporadic.
Family history
Ten percent of pheochromocytomas are linked to hereditary causes:
- Multiple endocrine neoplasia type 2 is a hereditary condition associated with medullary thyroid cancer and other types of cancer, including pheochromocytoma.
| MEN1 | MEN2 |
|---|---|
- Von Hippel-Lindau disease can result in tumors at multiple sites, including the central nervous system, endocrine system, pancreas and kidneys.
- Neurofibromatosis 1 results in multiple tumors in the skin (neurofibromas), pigmented skin spots and tumors of the optic nerve.
- Hereditary paraganglioma syndromes are inherited disorders that result in either pheochromocytomas or paragangliomas.
References
- ↑ National Cancer Institute. Physician Data Query Database 2015. National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_25_toc